Eve Dryer, VP, Patient Advocacy at Travere Therapeutics, has served as a patient advocacy leader for more than 25 years. Eve focuses broadly on incorporating best practices for inclusion of the patient voice both within her company and across the Rare Disease Patient and Caregiver Community.
Since joining Travere in 2019, Eve has championed the development of a robust company focus on building and supporting patient diversity and inclusion initiatives both internally and externally, and she worked together with the Black Women’s Health Imperative to launch the Rare Disease Diversity Coalition.
She also launched Travere’s Rare Disease Patient Advisory Council, consisting of 20 patients/caregivers, representing multiple therapeutic categories. RDPAC members provide non-branded input and unmet needs insights to teams across the company.
We previously launched Teens for Pink, engaging African American teenagers in breast cancer education and helping as family healthcare navigators. She spent 15 years as founder and president of a Philadelphia-based healthcare PR agency, with clients including AstraZeneca, GlaxoSmithKline, Janssen and Eisai.
She is on the Board of Sisters Network Inc., was the Healthcare Businesswomen’s Association 2013 global STAR honoree and was recognized in the PharmaVOICE 100 in 2008, 2016 and 2021.
Since joining Travere in 2019, Eve has championed the development of a robust company focus on building and supporting patient diversity and inclusion initiatives both internally and externally, and she worked together with the Black Women’s Health Imperative to launch the Rare Disease Diversity Coalition.
She also launched Travere’s Rare Disease Patient Advisory Council, consisting of 20 patients/caregivers, representing multiple therapeutic categories. RDPAC members provide non-branded input and unmet needs insights to teams across the company.
We previously launched Teens for Pink, engaging African American teenagers in breast cancer education and helping as family healthcare navigators. She spent 15 years as founder and president of a Philadelphia-based healthcare PR agency, with clients including AstraZeneca, GlaxoSmithKline, Janssen and Eisai.
She is on the Board of Sisters Network Inc., was the Healthcare Businesswomen’s Association 2013 global STAR honoree and was recognized in the PharmaVOICE 100 in 2008, 2016 and 2021.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5
